Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	endopolyphosphatase activity	NUDT11 NUDT4 NUDT10	3.28e-07	5	65	3	GO:0000298
GeneOntologyMolecularFunction	bis(5'-adenosyl)-hexaphosphatase activity	NUDT11 NUDT4 NUDT10	3.28e-07	5	65	3	GO:0034431
GeneOntologyMolecularFunction	diphosphoinositol-polyphosphate diphosphatase activity	NUDT11 NUDT4 NUDT10	3.28e-07	5	65	3	GO:0008486
GeneOntologyMolecularFunction	bis(5'-adenosyl)-pentaphosphatase activity	NUDT11 NUDT4 NUDT10	6.54e-07	6	65	3	GO:0034432
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	DOCK5 RAPGEF6 DOCK7 MCF2L DOCK6	9.32e-04	231	65	5	GO:0005085
GeneOntologyMolecularFunction	muscle alpha-actinin binding	LDB3 MYPN	1.07e-03	15	65	2	GO:0051371
GeneOntologyMolecularFunction	1-phosphatidylinositol binding	ZFYVE9 MCF2L	1.37e-03	17	65	2	GO:0005545
GeneOntologyBiologicalProcess	adenosine 5'-(hexahydrogen pentaphosphate) metabolic process	NUDT11 NUDT4 NUDT10	3.12e-07	5	66	3	GO:1901910
GeneOntologyBiologicalProcess	adenosine 5'-(hexahydrogen pentaphosphate) catabolic process	NUDT11 NUDT4 NUDT10	3.12e-07	5	66	3	GO:1901911
GeneOntologyBiologicalProcess	diadenosine pentaphosphate catabolic process	NUDT11 NUDT4 NUDT10	3.12e-07	5	66	3	GO:1901907
GeneOntologyBiologicalProcess	diadenosine pentaphosphate metabolic process	NUDT11 NUDT4 NUDT10	3.12e-07	5	66	3	GO:1901906
GeneOntologyBiologicalProcess	diadenosine hexaphosphate catabolic process	NUDT11 NUDT4 NUDT10	3.12e-07	5	66	3	GO:1901909
GeneOntologyBiologicalProcess	diadenosine hexaphosphate metabolic process	NUDT11 NUDT4 NUDT10	3.12e-07	5	66	3	GO:1901908
GeneOntologyBiologicalProcess	diphosphoinositol polyphosphate metabolic process	NUDT11 NUDT4 NUDT10	3.12e-07	5	66	3	GO:0071543
GeneOntologyBiologicalProcess	diadenosine polyphosphate catabolic process	NUDT11 NUDT4 NUDT10	6.22e-07	6	66	3	GO:0015961
GeneOntologyBiologicalProcess	diadenosine polyphosphate metabolic process	NUDT11 NUDT4 NUDT10	2.59e-06	9	66	3	GO:0015959
Domain	DOCK_C	DOCK5 DOCK7 DOCK6	6.51e-06	11	65	3	IPR010703
Domain	DHR-1_domain	DOCK5 DOCK7 DOCK6	6.51e-06	11	65	3	IPR027007
Domain	DHR_2	DOCK5 DOCK7 DOCK6	6.51e-06	11	65	3	PS51651
Domain	DHR_1	DOCK5 DOCK7 DOCK6	6.51e-06	11	65	3	PS51650
Domain	DOCK-C2	DOCK5 DOCK7 DOCK6	6.51e-06	11	65	3	PF14429
Domain	DHR-2	DOCK5 DOCK7 DOCK6	6.51e-06	11	65	3	IPR027357
Domain	DHR-2	DOCK5 DOCK7 DOCK6	6.51e-06	11	65	3	PF06920
Domain	DOCK	DOCK5 DOCK7 DOCK6	6.51e-06	11	65	3	IPR026791
Domain	NUDIX_hydrolase_CS	NUDT11 NUDT4 NUDT10	8.65e-06	12	65	3	IPR020084
Domain	ZINC_FINGER_C2H2_2	IKZF2 ZNF684 FEZF2 ZNF549 ZNF804B ZNF70 IKZF1 ZNF721 ZNF223 ZNF230 ZBTB24 ZNF284	1.27e-05	775	65	12	PS50157
Domain	ZINC_FINGER_C2H2_1	IKZF2 ZNF684 FEZF2 ZNF549 ZNF804B ZNF70 IKZF1 ZNF721 ZNF223 ZNF230 ZBTB24 ZNF284	1.31e-05	777	65	12	PS00028
Domain	Znf_C2H2-like	IKZF2 ZNF684 FEZF2 ZNF549 ZNF804B ZNF70 IKZF1 ZNF721 ZNF223 ZNF230 ZBTB24 ZNF284	1.66e-05	796	65	12	IPR015880
Domain	Znf_C2H2	IKZF2 ZNF684 FEZF2 ZNF549 ZNF804B ZNF70 IKZF1 ZNF721 ZNF223 ZNF230 ZBTB24 ZNF284	1.86e-05	805	65	12	IPR007087
Domain	ZnF_C2H2	IKZF2 ZNF684 FEZF2 ZNF549 ZNF804B ZNF70 IKZF1 ZNF721 ZNF223 ZNF230 ZBTB24 ZNF284	1.93e-05	808	65	12	SM00355
Domain	-	IKZF2 ZNF684 FEZF2 ZNF549 ZNF70 IKZF1 ZNF721 ZNF223 ZNF230 ZBTB24 ZNF284	2.02e-05	679	65	11	3.30.160.60
Domain	zf-C2H2	IKZF2 ZNF684 FEZF2 ZNF549 ZNF70 IKZF1 ZNF721 ZNF223 ZNF230 ZBTB24 ZNF284	2.44e-05	693	65	11	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	IKZF2 ZNF684 FEZF2 ZNF549 ZNF70 IKZF1 ZNF721 ZNF223 ZNF230 ZBTB24 ZNF284	2.48e-05	694	65	11	IPR013087
Domain	NUDIX_BOX	NUDT11 NUDT4 NUDT10	7.73e-05	24	65	3	PS00893
Domain	NUDIX	NUDT11 NUDT4 NUDT10	7.73e-05	24	65	3	PF00293
Domain	NUDIX	NUDT11 NUDT4 NUDT10	9.88e-05	26	65	3	PS51462
Domain	-	NUDT11 NUDT4 NUDT10	1.24e-04	28	65	3	3.90.79.10
Domain	NUDIX_hydrolase_dom-like	NUDT11 NUDT4 NUDT10	1.24e-04	28	65	3	IPR015797
Domain	NUDIX_hydrolase_dom	NUDT11 NUDT4 NUDT10	1.38e-04	29	65	3	IPR000086
Domain	DUF3398	DOCK7 DOCK6	1.77e-04	6	65	2	PF11878
Domain	DOCK_C/D_N	DOCK7 DOCK6	1.77e-04	6	65	2	IPR021816
Domain	Znf_FYVE	RUFY2 ZFYVE9 SYTL4	3.11e-04	38	65	3	IPR000306
Domain	ZF_FYVE	RUFY2 ZFYVE9 SYTL4	3.63e-04	40	65	3	PS50178
Domain	zf-C2H2_6	ZNF684 FEZF2 ZNF549 ZNF721 ZBTB24 ZNF284	7.73e-04	314	65	6	PF13912
Domain	PDZ	LDB3 RAPGEF6 LNX2 MYO18A	1.48e-03	141	65	4	PF00595
Domain	PDZ	LDB3 RAPGEF6 LNX2 MYO18A	1.76e-03	148	65	4	SM00228
Domain	-	LDB3 RAPGEF6 LNX2 MYO18A	1.85e-03	150	65	4	2.30.42.10
Domain	PDZ	LDB3 RAPGEF6 LNX2 MYO18A	1.90e-03	151	65	4	PS50106
Domain	PDZ	LDB3 RAPGEF6 LNX2 MYO18A	1.94e-03	152	65	4	IPR001478
Domain	FYVE	RUFY2 ZFYVE9	4.56e-03	29	65	2	PF01363
Domain	FYVE	RUFY2 ZFYVE9	4.56e-03	29	65	2	SM00064
Domain	-	RUFY2 TRAF6 LNX2 ZFYVE9 SYTL4 USP3	4.66e-03	449	65	6	3.30.40.10
Domain	Znf_RING/FYVE/PHD	RUFY2 TRAF6 LNX2 ZFYVE9 SYTL4 USP3	5.18e-03	459	65	6	IPR013083
Domain	RA	RAPGEF6 GRB10	5.20e-03	31	65	2	SM00314
Domain	cNMP	RAPGEF6 PNPLA7	6.23e-03	34	65	2	SM00100
Domain	Znf_FYVE-rel	RUFY2 ZFYVE9	6.23e-03	34	65	2	IPR017455
Domain	cNMP_binding	RAPGEF6 PNPLA7	6.23e-03	34	65	2	PF00027
Domain	cNMP-bd_dom	RAPGEF6 PNPLA7	6.59e-03	35	65	2	IPR000595
Domain	CNMP_BINDING_3	RAPGEF6 PNPLA7	6.59e-03	35	65	2	PS50042
Domain	RA	RAPGEF6 GRB10	6.96e-03	36	65	2	PF00788
Domain	RA	RAPGEF6 GRB10	7.34e-03	37	65	2	PS50200
Domain	Myosin_head_motor_dom	MYO18A MYO1B	7.73e-03	38	65	2	IPR001609
Domain	cNMP-bd-like	RAPGEF6 PNPLA7	7.73e-03	38	65	2	IPR018490
Domain	MYOSIN_MOTOR	MYO18A MYO1B	7.73e-03	38	65	2	PS51456
Domain	Myosin_head	MYO18A MYO1B	7.73e-03	38	65	2	PF00063
Domain	MYSc	MYO18A MYO1B	7.73e-03	38	65	2	SM00242
Domain	KRAB	ZNF684 ZNF549 ZNF223 ZNF230 ZNF284	8.12e-03	358	65	5	PS50805
Domain	KRAB	ZNF684 ZNF549 ZNF223 ZNF230 ZNF284	8.12e-03	358	65	5	PF01352
Domain	RA_dom	RAPGEF6 GRB10	8.54e-03	40	65	2	IPR000159
Domain	KRAB	ZNF684 ZNF549 ZNF223 ZNF230 ZNF284	9.18e-03	369	65	5	SM00349
Domain	KRAB	ZNF684 ZNF549 ZNF223 ZNF230 ZNF284	9.29e-03	370	65	5	IPR001909
Pathway	REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL	NUDT11 NUDT4 NUDT10	4.10e-06	10	47	3	MM14709
Pathway	REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL	NUDT11 NUDT4 NUDT10	4.10e-06	10	47	3	M27051
Pubmed	Cloning and characterisation of hAps1 and hAps2, human diadenosine polyphosphate-metabolising Nudix hydrolases.	NUDT11 NUDT4 NUDT10	6.53e-09	3	66	3	12121577
Pubmed	Nudix hydrolases that degrade dinucleoside and diphosphoinositol polyphosphates also have 5-phosphoribosyl 1-pyrophosphate (PRPP) pyrophosphatase activity that generates the glycolytic activator ribose 1,5-bisphosphate.	NUDT11 NUDT4 NUDT10	2.61e-08	4	66	3	12370170
Pubmed	Paternal deletion of Meg1/Grb10 DMR causes maternalization of the Meg1/Grb10 cluster in mouse proximal Chromosome 11 leading to severe pre- and postnatal growth retardation.	GRB10 IKZF1 DDC	6.51e-08	5	66	3	19174477
Pubmed	Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.	GRB10 IKZF1 DDC	6.51e-08	5	66	3	23512250
Pubmed	Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.	DOCK5 DOCK7 DOCK6	2.34e-06	14	66	3	12432077
Pubmed	Germline genomic variants associated with childhood acute lymphoblastic leukemia.	IKZF1 ZNF230 DDC	2.92e-06	15	66	3	19684603
Pubmed	An adjacent pair of human NUDT genes on chromosome X are preferentially expressed in testis and encode two new isoforms of diphosphoinositol polyphosphate phosphohydrolase.	NUDT11 NUDT10	3.55e-06	2	66	2	12105228
Pubmed	Helios deficiency has minimal impact on T cell development and function.	IKZF2 IKZF1	3.55e-06	2	66	2	19620299
Pubmed	A genetic locus in 7p12.2 associated with treatment resistant schizophrenia.	GRB10 DDC	3.55e-06	2	66	2	25223841
Pubmed	Localization of endogenous Grb10 to the mitochondria and its interaction with the mitochondrial-associated Raf-1 pool.	RAF1 GRB10	3.55e-06	2	66	2	10585452
Pubmed	Paralogous murine Nudt10 and Nudt11 genes have differential expression patterns but encode identical proteins that are physiologically competent diphosphoinositol polyphosphate phosphohydrolases.	NUDT11 NUDT10	3.55e-06	2	66	2	12689335
Pubmed	Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes.	IKZF2 IKZF1	3.55e-06	2	66	2	17681952
Pubmed	[Expression characteristics of isoforms of Ikaros and Helios in patients with leukemia and their mechanism].	IKZF2 IKZF1	3.55e-06	2	66	2	22931634
Pubmed	Differential expansion of zinc-finger transcription factor loci in homologous human and mouse gene clusters.	ZNF223 ZNF230 ZNF284	7.27e-06	20	66	3	12743021
Pubmed	Tissue-specific Grb10/Ddc insulator drives allelic architecture for cardiac development.	GRB10 DDC	1.06e-05	3	66	2	36108632
Pubmed	Overexpression of novel short isoforms of Helios in a patient with T-cell acute lymphoblastic leukemia.	IKZF2 IKZF1	1.06e-05	3	66	2	11937265
Pubmed	Genomic imprinting of Dopa decarboxylase in heart and reciprocal allelic expression with neighboring Grb10.	GRB10 DDC	1.06e-05	3	66	2	17967881
Pubmed	Ubiquitin-specific protease 3 targets TRAF6 for deubiquitination and suppresses IL-1β induced chondrocyte apoptosis.	TRAF6 USP3	1.06e-05	3	66	2	31056254
Pubmed	Results of Detailed Investigations Into Stevens-Johnson Syndrome With Severe Ocular Complications.	TLR3 IKZF1	1.06e-05	3	66	2	30481825
Pubmed	Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors.	IKZF2 IKZF1	1.06e-05	3	66	2	9560339
Pubmed	Interaction of the Grb10 adapter protein with the Raf1 and MEK1 kinases.	RAF1 GRB10	1.06e-05	3	66	2	9553107
Pubmed	Imprinted Gene Expression and Function of the Dopa Decarboxylase Gene in the Developing Heart.	GRB10 DDC	1.06e-05	3	66	2	34239874
Pubmed	Analysis of Ikaros family splicing variants in human hematopoietic lineages.	IKZF2 IKZF1	1.06e-05	3	66	2	20432734
Pubmed	Expression patterns of Ikaros family members during positive selection and lineage commitment of human thymocytes.	IKZF2 IKZF1	1.06e-05	3	66	2	27502439
Pubmed	Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction.	IKZF1 IL7R	1.06e-05	3	66	2	27322554
Pubmed	Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination.	TRAF6 TLR3	1.06e-05	3	66	2	24321786
Pubmed	Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma.	IKZF2 IKZF1	1.06e-05	3	66	2	18332232
Pubmed	Distinct physiological and behavioural functions for parental alleles of imprinted Grb10.	GRB10 DDC	2.12e-05	4	66	2	21270893
Pubmed	STAT5 activation underlies IL7 receptor-dependent B cell development.	RAF1 IL7R	2.12e-05	4	66	2	15067053
Pubmed	Grb10 and active Raf-1 kinase promote Bad-dependent cell survival.	RAF1 GRB10	2.12e-05	4	66	2	17535812
Pubmed	Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.	NUDT11 NUDT10	3.53e-05	5	66	2	18264098
Pubmed	Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice.	IKZF1 IL7R	3.53e-05	5	66	2	34193976
Pubmed	Pellino3 targets the IRF7 pathway and facilitates autoregulation of TLR3- and viral-induced expression of type I interferons.	TRAF6 TLR3	3.53e-05	5	66	2	23042151
Pubmed	Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities.	IKZF2 IKZF1	3.53e-05	5	66	2	10978333
Pubmed	Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins.	DOCK5 DOCK7	3.53e-05	5	66	2	22158624
Pubmed	IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination.	TRAF6 TLR3	3.53e-05	5	66	2	17878161
Pubmed	Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.	IKZF1 DDC	3.53e-05	5	66	2	28768142
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	DOCK5 MYO18A DOCK7 MYO1B DOCK6	4.22e-05	202	66	5	33005030
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	STK36 RAPGEF6 CTDP1 NPRL3 GRB10 JOSD1 MCF2L DOCK6 SIL1 PCNT	4.22e-05	1105	66	10	35748872
Pubmed	Discovery and refinement of loci associated with lipid levels.	RAF1 DOCK7 FADS2 IKZF1 DOCK6	5.19e-05	211	66	5	24097068
Pubmed	JNK-binding protein 1 regulates NF-kappaB activation through TRAF2 and TAK1.	RAF1 TRAF6	5.29e-05	6	66	2	19385034
Pubmed	TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human cornea.	TRAF6 TLR3	5.29e-05	6	66	2	25754842
Pubmed	IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways.	TRAF6 TLR3	7.40e-05	7	66	2	16484229
Pubmed	Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.	TRAF6 TLR3	7.40e-05	7	66	2	20047764
Pubmed	MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo.	TLR3 IKZF1	7.40e-05	7	66	2	16272328
Pubmed	Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction.	TRAF6 TLR3	9.86e-05	8	66	2	19795416
Pubmed	Stage-specific control of early B cell development by the transcription factor Ikaros.	IKZF1 IL7R	9.86e-05	8	66	2	24509509
Pubmed	WDFY1 mediates TLR3/4 signaling by recruiting TRIF.	TRAF6 TLR3	9.86e-05	8	66	2	25736436
Pubmed	MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2.	TRAF6 TLR3	9.86e-05	8	66	2	19596990
Pubmed	Genomic organization of the region spanning D14Mit262 and D14Mit86 on mouse chromosome 14 and exclusion of Adam28 and Adamdec1 as the cataract-causing gene, lr2.	DOCK5 ADAMDEC1	9.86e-05	8	66	2	17268172
Pubmed	Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation.	TRAF6 TLR3	9.86e-05	8	66	2	16115877
Pubmed	The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I.	TRAF6 TLR3	1.27e-04	9	66	2	16210631
Pubmed	Glycogen synthase kinase 3β ubiquitination by TRAF6 regulates TLR3-mediated pro-inflammatory cytokine production.	TRAF6 TLR3	1.27e-04	9	66	2	25828701
Pubmed	Helios transcription factor expression depends on Gsx2 and Dlx1&2 function in developing striatal matrix neurons.	IKZF2 IKZF1	1.27e-04	9	66	2	22142223
Pubmed	Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development.	IKZF1 IL7R	1.27e-04	9	66	2	19734904
Pubmed	Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos.	IKZF2 IKZF1	1.27e-04	9	66	2	22638570
Pubmed	Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.	TRAF6 TLR3	1.27e-04	9	66	2	14982987
Pubmed	Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.	TRAF6 TLR3	1.58e-04	10	66	2	11923871
Pubmed	Both the pre-BCR and the IL-7Ralpha are essential for expansion at the pre-BII cell stage in vivo.	CR2 IL7R	1.58e-04	10	66	2	15909309
Pubmed	Biological, clinical and population relevance of 95 loci for blood lipids.	RAF1 DOCK7 FADS2 DOCK6	1.75e-04	146	66	4	20686565
Pubmed	Multiple newly identified loci associated with prostate cancer susceptibility.	NUDT11 NUDT10	1.93e-04	11	66	2	18264097
Pubmed	The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3.	TRAF6 TLR3	1.93e-04	11	66	2	23962979
Pubmed	Id2-, RORgammat-, and LTbetaR-independent initiation of lymphoid organogenesis in ocular immunity.	TRAF6 IL7R	1.93e-04	11	66	2	19822644
Pubmed	pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells.	TRAF6 TLR3	1.93e-04	11	66	2	10066798
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RAF1 RAPGEF6 LNX2 DOCK7 INPP5F DOCK6	2.04e-04	446	66	6	24255178
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	PPIG EIF2S2 MYO18A SIL1 PCNT	2.12e-04	285	66	5	32838362
Pubmed	Polymorphisms in interleukin-1 receptor-associated kinase 4 are associated with total serum IgE.	TRAF6 TLR3	2.31e-04	12	66	2	19254290
Pubmed	Direct and indirect control of mitogen-activated protein kinase pathway-associated components, BRAP/IMP E3 ubiquitin ligase and CRAF/RAF1 kinase, by the deubiquitylating enzyme USP15.	RAF1 TRAF6 LNX2	2.39e-04	63	66	3	23105109
Pubmed	An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling.	TRAF6 DOCK7	2.73e-04	13	66	2	30254148
Pubmed	Ikaros confers early temporal competence to mouse retinal progenitor cells.	IKZF2 IKZF1	2.73e-04	13	66	2	18940586
Pubmed	--LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation.	TRAF6 TLR3	2.73e-04	13	66	2	27810922
Pubmed	Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.	TRAF6 TLR3	2.73e-04	13	66	2	18423196
Pubmed	A molecular dissection of the repression circuitry of Ikaros.	IKZF2 IKZF1	3.18e-04	14	66	2	12015313
Pubmed	Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.	RPUSD4 USP3	3.18e-04	14	66	2	20445134
Pubmed	E3 ubiquitin ligase CHIP facilitates Toll-like receptor signaling by recruiting and polyubiquitinating Src and atypical PKC{zeta}.	TRAF6 TLR3	3.18e-04	14	66	2	21911421
Pubmed	Validation of genome-wide prostate cancer associations in men of African descent.	NUDT11 NUDT10	3.67e-04	15	66	2	21071540
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	RUFY2 ZFYVE9 WFS1 SCYL3 FADS2 DOCK6	3.92e-04	504	66	6	34432599
Pubmed	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	IKZF1 DDC	4.18e-04	16	66	2	22076464
Pubmed	Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting.	IKZF1 IL7R	4.18e-04	16	66	2	10687308
Pubmed	Nebulette knockout mice have normal cardiac function, but show Z-line widening and up-regulation of cardiac stress markers.	LDB3 MYPN	4.18e-04	16	66	2	25987543
Pubmed	PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors.	IKZF1 IL7R	4.74e-04	17	66	2	11869689
Pubmed	Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice.	IKZF1 IL7R	4.74e-04	17	66	2	9175833
Pubmed	Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.	NAA25 IL7R	4.74e-04	17	66	2	17554260
Pubmed	Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR .	TRAF6 TLR3	4.74e-04	17	66	2	12609980
Pubmed	Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.	RAF1 LDB3 WFS1 IKZF1 DDC ZBTB24 SIL1	5.11e-04	742	66	7	26871637
Pubmed	A mutation in the Srrm4 gene causes alternative splicing defects and deafness in the Bronx waltzer mouse.	RUFY2 RAPGEF6 MCF2L	5.77e-04	85	66	3	23055939
Pubmed	Ikaros promotes early-born neuronal fates in the cerebral cortex.	IKZF2 IKZF1	5.94e-04	19	66	2	23382203
Pubmed	Lymph sacs are not required for the initiation of lymph node formation.	CR2 IL7R	5.94e-04	19	66	2	19060331
Pubmed	Animal Models of Congenital Cardiomyopathies Associated With Mutations in Z-Line Proteins.	LDB3 MYPN	5.94e-04	19	66	2	27171814
Pubmed	The LIM homeobox gene Isl1 is required for the correct development of the striatonigral pathway in the mouse.	IKZF2 IKZF1	6.59e-04	20	66	2	24082127
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	RAF1 TLR3 MYO18A DOCK7	6.70e-04	208	66	4	33230847
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	RAPGEF6 MYPN DOCK7 WIPI2	6.82e-04	209	66	4	36779422
Pubmed	Mesenchymal cells are required for functional development of thymic epithelial cells.	IKZF1 IL7R	7.28e-04	21	66	2	17625108
Pubmed	Neurog2 and Ascl1 together regulate a postmitotic derepression circuit to govern laminar fate specification in the murine neocortex.	FEZF2 IKZF1	7.28e-04	21	66	2	28584103
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	RUFY2 DOCK5 RAF1 SYTL4 SCYL3 DOCK7	7.39e-04	569	66	6	30639242
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	RAF1 RAPGEF6 MYPN SCYL3 EIF2S2 DOCK7 GRB10 DOCK6	7.61e-04	1038	66	8	26673895
Pubmed	USP37 is a SNAI1 deubiquitinase.	JOSD1 USP3	9.53e-04	24	66	2	31911859
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RAF1 RAPGEF6 DOCK7 INPP5F PCNT	1.20e-03	418	66	5	34709266
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DOCK5 RAF1 STK36 RAPGEF6 PCNT	1.36e-03	430	66	5	35044719
Pubmed	Genetic loci associated with lipid concentrations and cardiovascular risk factors in the Korean population.	DOCK7 FADS2	1.39e-03	29	66	2	20972250
Cytoband	7p12.2	GRB10 DDC	4.25e-05	7	66	2	7p12.2
Cytoband	Ensembl 112 genes in cytogenetic band chr7p12	GRB10 IKZF1 DDC	1.06e-04	63	66	3	chr7p12
Cytoband	8p21.2	DOCK5 ADAMDEC1	5.98e-04	25	66	2	8p21.2
Cytoband	19q13.31	ZNF230 ZNF284	8.06e-04	29	66	2	19q13.31
Cytoband	10q21.3	RUFY2 MYPN	1.11e-03	34	66	2	10q21.3
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	IKZF2 ZNF684 FEZF2 ZNF549 ZNF70 IKZF1 ZNF721 ZNF223 ZNF230 ZBTB24 ZNF284	3.25e-06	718	50	11	28
GeneFamily	Nudix hydrolase family	NUDT11 NUDT4 NUDT10	3.87e-05	24	50	3	667
GeneFamily	PDZ domain containing	LDB3 RAPGEF6 LNX2 MYO18A	8.19e-04	152	50	4	1220
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	RUFY2 ZFYVE9	3.31e-03	31	50	2	81
Coexpression	GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP	LDB3 TLR3 JOSD1 MCF2L CR2 USP3	1.04e-05	197	66	6	M5295
Coexpression	GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP	LDB3 TLR3 JOSD1 MCF2L CR2 USP3	1.07e-05	198	66	6	M5299
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|368C / Donor, Lineage, Cell class and subclass (all cells)	TRAF6 LNX2 ZNF230 CCDC171 IL7R	5.23e-06	169	66	5	0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74
ToppCell	Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175\|Adult / Lineage, Cell type, age group and donor	SULF2 MYO18A GRB10 ZNF230 MCF2L	6.55e-06	177	66	5	c9f269765c7d5d29caab75910e51645606ed562e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	SYTL4 TLR3 DNAH2 MYO1B DOCK6	1.18e-05	200	66	5	aafe594c88710f8c53d59667cdac5035e08f5511
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	SYTL4 TLR3 DNAH2 MYO1B DOCK6	1.18e-05	200	66	5	a6f0f5f644b7262878b0b9d4d90ee407c4124dd9
Drug	diadenosine 5',5''''-P1,P6-hexaphosphate	NUDT11 NUDT10	8.28e-06	2	66	2	ctd:C070070
Drug	adenosine 5'-tetraphosphate	NUDT11 NUDT10	8.28e-06	2	66	2	ctd:C017991
Drug	adenosine 5'-pentaphosphate	NUDT11 NUDT10	8.28e-06	2	66	2	ctd:C048567
Drug	2bxt	STK36 CR2 NDUFB7	2.18e-05	19	66	3	CID011363491
Drug	ST021200; Up 200; 10uM; MCF7; HT_HG-U133A	LDB3 TRAF6 FADS2 IKZF1 ZNF223 WIPI2	2.36e-05	198	66	6	7488_UP
Disease	HbA1c measurement	RUFY2 RAF1 NAA25 WFS1 MYPN NPRL3 FADS2 RNASE12 MCF2L CR2	2.12e-06	675	65	10	EFO_0004541
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	DOCK7 FADS2 DOCK6	2.87e-06	13	65	3	OBA_2045159
Disease	lipoprotein measurement	NAA25 SULF2 DOCK7 FADS2 DOCK6	3.61e-06	105	65	5	EFO_0004732
Disease	level of Phosphatidylinositol (18:0_18:1) in blood serum	DOCK7 FADS2 DOCK6	8.13e-06	18	65	3	OBA_2045155
Disease	level of Phosphatidylinositol (18:0_18:2) in blood serum	DOCK7 FADS2 DOCK6	1.32e-05	21	65	3	OBA_2045156
Disease	phospholipid measurement	NAA25 SULF2 DOCK7 FADS2 DOCK6	1.47e-05	140	65	5	EFO_0004639
Disease	type 1 diabetes mellitus	NAA25 DNAH2 GRB10 FADS2 IKZF1 IL7R	1.58e-05	242	65	6	MONDO_0005147
Disease	level of Phosphatidylinositol (18:0_20:4) in blood serum	DOCK7 FADS2 DOCK6	1.75e-05	23	65	3	OBA_2045158
Disease	level of Phosphatidylcholine (18:2_18:2) in blood serum	DOCK7 FADS2	7.13e-05	6	65	2	OBA_2045106
Disease	level of Phosphatidylinositol (18:1_18:2) in blood serum	DOCK7 FADS2	7.13e-05	6	65	2	OBA_2045160
Disease	1-stearoyl-2-linoleoyl-GPC (18:0/18:2) measurement	DOCK7 FADS2	7.13e-05	6	65	2	EFO_0800404
Disease	level of Phosphatidylcholine (16:0_18:0) in blood serum	DOCK7 FADS2	7.13e-05	6	65	2	OBA_2045069
Disease	1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) measurement	DOCK7 FADS2	9.96e-05	7	65	2	EFO_0800609
Disease	Familial dilated cardiomyopathy	RAF1 LDB3 MYPN	1.27e-04	44	65	3	C0340427
Disease	1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement	DOCK7 FADS2	1.33e-04	8	65	2	EFO_0800610
Disease	Ataxias, Hereditary	WFS1 SIL1	1.33e-04	8	65	2	C0004138
Disease	1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement	DOCK7 FADS2	1.33e-04	8	65	2	EFO_0800396
Disease	level of Phosphatidylinositol (16:0_18:2) in blood serum	DOCK7 FADS2	1.33e-04	8	65	2	OBA_2045153
Disease	level of Phosphatidylcholine (18:1_18:1) in blood serum	DOCK7 FADS2	1.33e-04	8	65	2	OBA_2045099
Disease	1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement	DOCK7 FADS2	1.70e-04	9	65	2	EFO_0800439
Disease	1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) measurement	DOCK7 FADS2	1.70e-04	9	65	2	EFO_0800412
Disease	insulin response measurement	GRB10 IKZF1	1.70e-04	9	65	2	EFO_0008473
Disease	basophil count, eosinophil count	IKZF2 GRB10 FADS2 IKZF1 IL7R	1.93e-04	241	65	5	EFO_0004842, EFO_0005090
Disease	1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement	DOCK7 FADS2	2.13e-04	10	65	2	EFO_0800469
Disease	oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement	DOCK7 FADS2	2.13e-04	10	65	2	EFO_0800333
Disease	level of Phosphatidylcholine (16:0_20:3) in blood serum	DOCK7 FADS2	2.13e-04	10	65	2	OBA_2045075
Disease	Immunoglobulin Deficiency, Late-Onset	IKZF1 CR2	2.59e-04	11	65	2	C2936665
Disease	Acquired Hypogammaglobulinemia	IKZF1 CR2	2.59e-04	11	65	2	C2936664
Disease	level of Phosphatidylinositol (16:0_18:1) in blood serum	DOCK7 FADS2	3.11e-04	12	65	2	OBA_2045152
Disease	level of Phosphatidylinositol (18:0_20:3) in blood serum	DOCK7 FADS2	3.11e-04	12	65	2	OBA_2045157
Disease	pyruvate measurement	PPIG ZNF804B MYO18A NPRL3 IKZF1	3.15e-04	268	65	5	EFO_0010117
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	IKZF2 IKZF1 IL7R	3.35e-04	61	65	3	C1961102
Disease	Common variable immunodeficiency	IKZF1 CR2	3.67e-04	13	65	2	cv:C0009447
Disease	fatty acid measurement, fetal genotype effect measurement, breast milk measurement	ZNF804B FADS2	3.67e-04	13	65	2	EFO_0005110, EFO_0007959, EFO_0009092
Disease	1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement	DOCK7 FADS2	3.67e-04	13	65	2	EFO_0800413
Disease	hypothyroidism	NAA25 ZNF804B TLR3 FADS2 IL7R	4.11e-04	284	65	5	EFO_0004705
Disease	acute lymphoblastic leukemia	IKZF1 ZNF230 DDC	4.23e-04	66	65	3	EFO_0000220
Disease	1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement	DOCK7 FADS2	4.27e-04	14	65	2	EFO_0022085
Disease	level of Phosphatidylcholine (18:1_18:2) in blood serum	DOCK7 FADS2	4.27e-04	14	65	2	OBA_2045100
Disease	fatty acid measurement, breast milk measurement, parental genotype effect measurement	ZNF804B FADS2	4.27e-04	14	65	2	EFO_0005110, EFO_0005939, EFO_0009092
Disease	fatty acid measurement, linoleic acid measurement	NAA25 FADS2 CCDC171	4.62e-04	68	65	3	EFO_0005110, EFO_0006807
Disease	Common Variable Immunodeficiency	IKZF1 CR2	4.93e-04	15	65	2	C0009447
Disease	high density lipoprotein particle size measurement	SULF2 FADS2 RNASE12 DOCK6	5.48e-04	170	65	4	EFO_0008592
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	SULF2 DOCK7 NPRL3 FADS2 DOCK6	5.51e-04	303	65	5	EFO_0004612, EFO_0020945
Disease	1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement	DOCK7 FADS2	5.62e-04	16	65	2	EFO_0800184
Disease	level of Phosphatidylcholine (18:0_18:2) in blood serum	DOCK7 FADS2	5.62e-04	16	65	2	OBA_2045090
Disease	phospholipids in large HDL measurement	SULF2 FADS2 DOCK6	5.68e-04	73	65	3	EFO_0022190
Disease	total lipids in large HDL	SULF2 FADS2 DOCK6	5.91e-04	74	65	3	EFO_0022189
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	SULF2 DOCK7 FADS2 RNASE12 DOCK6	6.29e-04	312	65	5	EFO_0004612, EFO_0010351
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	SULF2 DOCK7 FADS2 RNASE12 DOCK6	6.57e-04	315	65	5	EFO_0004612, EFO_0008591
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	SULF2 DOCK7 FADS2 RNASE12 DOCK6	6.57e-04	315	65	5	EFO_0004574, EFO_0004612
Disease	phosphatidylcholine 36:4 measurement	FADS2 SIL1	7.15e-04	18	65	2	EFO_0010382
Disease	level of Phosphatidylcholine (15:0_18:2) in blood serum	DOCK7 FADS2	7.15e-04	18	65	2	OBA_2045065
Disease	free cholesterol in large HDL measurement	SULF2 FADS2 DOCK6	7.16e-04	79	65	3	EFO_0022157
Disease	lipid measurement, high density lipoprotein cholesterol measurement	SULF2 DOCK7 FADS2 RNASE12 DOCK6	8.10e-04	330	65	5	EFO_0004529, EFO_0004612
Disease	level of Phosphatidylcholine (16:0_18:2) in blood serum	DOCK7 FADS2	8.85e-04	20	65	2	OBA_2045071
Disease	systemic scleroderma	IKZF2 GRB10 CR2	8.86e-04	85	65	3	EFO_0000717
Disease	gestational age, birth measurement	OXR1 FADS2	9.77e-04	21	65	2	EFO_0005112, EFO_0006921
Disease	phosphatidylcholine 34:3 measurement	FADS2 MYO1B	1.07e-03	22	65	2	EFO_0010377
Disease	Ovarian Serous Adenocarcinoma	RAF1 STK36	1.17e-03	23	65	2	C1335177
Disease	phosphatidylinositol measurement	DOCK7 FADS2 DOCK6	1.22e-03	95	65	3	EFO_0010230
Disease	triacylglycerol 56:5 measurement	DOCK5 FADS2	1.50e-03	26	65	2	EFO_0010432
Disease	3-methoxytyrosine measurement	GRB10 DDC	1.62e-03	27	65	2	EFO_0021009
Disease	corpus callosum mid-anterior volume measurement	GRB10 WDR72	1.62e-03	27	65	2	EFO_0010297
Disease	upper respiratory tract disorder	IKZF1 IL7R	1.74e-03	28	65	2	MONDO_0004867
Disease	mean platelet volume	DOCK5 LNX2 SYTL4 DOCK7 FADS2 IKZF1 MCF2L WDR49	1.75e-03	1020	65	8	EFO_0004584
Disease	testosterone measurement	DOCK5 RAF1 SYTL4 MYPN GDF6 DNAH2 RNASE12 USP3 WDR72	1.85e-03	1275	65	9	EFO_0004908
Disease	reticulocyte count	DOCK5 NUDT4 OXR1 NPRL3 MYO1B IKZF1 USP3 WIPI2	2.04e-03	1045	65	8	EFO_0007986
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	DOCK7 FADS2 RNASE12 DOCK6	2.05e-03	243	65	4	EFO_0004612, EFO_0020944
Disease	antihyperlipidemic drug use measurement	DOCK7 FADS2 WDR72	2.11e-03	115	65	3	EFO_0803367
Disease	aortic stenosis	FADS2 DOCK6	2.13e-03	31	65	2	EFO_0000266
Disease	triacylglycerol 54:3 measurement	MYPN FADS2	2.13e-03	31	65	2	EFO_0010421
Disease	cholesterol to total lipids in very large HDL percentage	DOCK7 DOCK6	2.13e-03	31	65	2	EFO_0022243
Disease	reticulocyte measurement	DOCK5 NUDT4 OXR1 NPRL3 MYO1B IKZF1 USP3 WIPI2	2.13e-03	1053	65	8	EFO_0010700

Protein segments in the cluster

Peptide	Gene	Start	Entry
LHTRLRPHCKDFLEK	CTDP1	221	Q9Y5B0
DKHKFPKHQKEQLRC	CCDC171	846	Q6TFL3
KKIHLVPCHLRDKFV	DDC	431	P20711
CHKPVHAEYLEKLKL	NUDT10	131	Q8NFP7
CAVFRLLHEHKGKKA	RAF1	96	P04049
LHKIAPLVKSLCAKH	FADS2	396	O95864
SKKDRPLCKKHAHTI	LDB3	711	O75112
KDFCPLDRKRLHFKL	LNX2	81	Q8N448
CHKPVHAEYLEKLKL	NUDT4	131	Q9NZJ9
IKKSKLHFVHCFLPV	MYO18A	1036	Q92614
FHHILPKCKLARDLK	NPRL3	191	Q12980
LPDHKKTLEHLCKKP	IL7R	276	P16871
KFLKHHLRGKNCELL	JOSD1	171	Q15040
CHKPVHAEYLEKLKL	NUDT11	131	Q96G61
LRHIKLHSGEKPFKC	IKZF1	161	Q13422
RIHHFLCDIKPLLKL	OR12D2	171	P58182
LRHIKLHSGEKPFKC	IKZF2	156	Q9UKS7
CKLLHRQPKHLLAFL	EIF2S2	226	P20042
LEKLLKHHLQKGCSP	PCNT	3076	O95613
HHLIRLLKCKRDSFP	NDUFB7	61	P17568
LGHFEKPLFLELCKH	PNPLA7	146	Q6ZV29
KPLHYKSCLFHRVVK	PPIG	56	Q13427
NKAAKHLKTLRHPCL	SCYL3	51	Q8IZE3
LLKEKQRHRLHKFLC	OXR1	546	Q8N573
RLDFLAKHILHCKAK	FJX1	416	Q86VR8
IWFKKIPLCKVIHCH	CR2	706	P20023
LLEKLLLEHCRKHKY	DOCK5	1171	Q9H7D0
PKLFRHHNKLRLCFK	DOCK6	1961	Q96HP0
DPKLFRHHNKLRLCF	DOCK7	2051	Q96N67
HLFLHEKAVLFCKKR	MCF2L	861	O15068
LNKGVLPCKLKHHCI	GRB10	576	Q13322
NLKGHHVRLCKPCKL	GPR15L	51	Q6UWK7
VFCHLPDILTKRKLH	DNAH2	906	Q9P225
TCKKEHVFIHERPRK	RNASE12	61	Q5GAN4
LCKKHHFGINKPEKI	INPP5F	106	Q9Y2H2
FCRNFDLKKHVRKLH	FEZF2	426	Q8TBJ5
HGKKSRLRCSKKPLH	GDF6	346	Q6KF10
HKAEPLHLCHRLDKE	RPUSD4	141	Q96CM3
DKKLDHCLPLHGKIS	SYTL4	471	Q96C24
IKHFIKIALHCRECK	RAPGEF6	931	Q8TEU7
EHCLKHGLKVRKSFL	RUFY2	51	Q8WXA3
KKKVLFALCSLLRHF	SIL1	286	Q9H173
VSLKAPRKLKVCHFK	WIPI2	91	Q9Y4P8
PASAKHCRKLIHLLR	STK36	1296	Q9NRP7
LHEIVCPKKLHILHK	ADAMDEC1	41	O15204
CPKKLHILHKREIKN	ADAMDEC1	46	O15204
ECGKAFIKKSHLLRH	ZNF684	331	Q5T5D7
KKKHTLLCPDFARRG	ZC3H3	771	Q8IXZ2
VITHHLLKDPLCKRF	TLR3	816	O15455
LLKDPLCKRFKVHHA	TLR3	821	O15455
ISRFKKHKLIPCSPH	ZNF804B	631	A4D1E1
ECGKAFIHKKRLLEH	ZNF549	421	Q6P9A3
LNHKRLHCRKKPFKC	ZNF223	416	Q9UK11
KFHINIHILKDCPRR	TRAF6	171	Q9Y4K3
KHKRIHTGEKPFKCL	ZNF721	786	Q8TF20
PKEILHHERKAKQLC	WDR49	671	Q8IV35
GKSCLLHARKHLFPV	WDR72	546	Q3MJ13
AKRRHCILHTGKKPF	ZBTB24	476	O43167
QKLPKVLCLHLKRFH	USP3	401	Q9Y6I4
RKIHTLKKPHECDLC	ZNF70	271	Q9UC06
SILNHKKLHCRKKPF	ZNF230	406	Q9UIE0
HLKKKRPEECDCHKI	SULF2	651	Q8IWU5
AFLLKHHCVRKPSDL	XRRA1	91	Q6P2D8
KAFCLALCPHLKLLK	ZFYVE9	1341	O95405
LRHKRLHTGEKPFKC	ZNF284	471	Q2VY69
RLKLLAKHPCHIKKF	WFS1	756	O76024
HKELKRIFHLWRCKK	MYO1B	911	O43795
HKDLHCAKVLKAIGL	NAA25	41	Q14CX7
KCIAPIFDKRLKHFR	MYPN	941	Q86TC9